Efficacy of directly observed treatment of HIV infection: Experience in AIDS welfare homes

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 4, 2004, Pages 331-335

  Tinoco, I ^a   Giron Gonzalez J A ^a   Gonzalez Gonzalez M T ^b   Vergara De Campos, A ^c   Rodriguez Felix L ^d   Serrano, A ^e   Bascunana A ^e  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b Casa de Acogida Gerasa   (Spain)

^c HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^d HOSPITAL DE JEREZ   (Spain)

^e Universidad Pública de Navarra   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MALE; MORBIDITY; MORTALITY; OUTPATIENT; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SCORING SYSTEM; SOCIAL WELFARE; T LYMPHOCYTE; VIRUS LOAD; WELFARE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMBULATORY CARE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; DIRECTLY OBSERVED THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HOME CARE SERVICES; HUMANS; MALE; PATIENT COMPLIANCE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIAL WELFARE; SPAIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 2542429552     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-1099-8     Document Type: Article

References (19)

1. Stone VE (2001) Strategies for optimizing adherence to highly active anti-retroviral therapy: lessons from research and clinical practice. Clin Infect Dis 33:865-872
2. Woodward WC (1996) Should directly observed therapy be considered for treatment of HIV? JAMA 276:1956
3. Sherer R (1998) Adherence and antiretroviral therapy in injection drug users. JAMA 280:567-568
4. Sorensen JL, Mascovich A, Wall TL, DePhilippis D, Batki SL, Chesney M (1998) Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care 10:297-312
5. Mitty JA, Mckenzie M, Stenzel M, Flanigan T, Carpenter CCJ (1999) Modified directly observed therapy for treatment of human immunodeficiency virus. JAMA 282:1334
6. Chaulk CP, Kazandijian VA (1998) Directly observed therapy for treatment completion of pulmonary tuberculosis. JAMA 279:943-948
7. Babudiere S, Aceti A, D'Offizi GP, Carbonara S, Starnini G (2000) Directly observed therapy to treat HIV infection in prisoners. JAMA 284:179-180
8. Lanzafame M, Trevenzoli M, Cattelan AM, Lazzarini L, Vento Ercole Concia S (2000) Directly observed therapy in HIV therapy: a realistic perspective? J Acquir Immune Defic Syndr 25:200-201
9. Mitty JA, Stone VE, Sands M, Macalino G, Flanigan T (2002) Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clin Infect Dis 34:984-990
10. Farmer P, Leandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, Koenig SP, Castro A, Becerra MC, Sachs J, Attaran A, Kim JY (2001) Community-based approaches to HIV treatment in resource-poor setting. Lancet 358:404-409
11. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA (1998) Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA 280:78-86
12. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA (2000) Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 283:2936-2937
13. McCabe WR, Jackson GG (1962) Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 110:847-855
14. Centers for Diseases Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41:RR-17
15. Knobel H, Alonso J, Casado JL, Collazos J, Gonzalez J, Ruiz I, Kindelan JM, Carmona A, Juega J, Ocampo A, GEEMA Study Group (2002) Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study. AIDS 16:605-613
16. López-Suárez A, Fernández-Gutiérrez del Álamo C, Pérez-Guzmán E, Girón-González JA (1998) Adherence to antiretroviral treatment in asymptomatic HIV-infected patients. AIDS 12:685-686
17. Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM (1999) HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS 13:F35-43
18. Torre D, Tambini R (2002) Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study. HIV Clin Trials 3:1-8
19. Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A (1999) AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study. JAMA 282:2220-2226